-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UeSJHK3K364eHhmVA6hAQxxjuASWDimORNjiNqYc0I6ufAKqQvE464v7s+8mKoJr /41gwbmkLtA9U1u3HivPjw== 0001181431-10-047024.txt : 20100916 0001181431-10-047024.hdr.sgml : 20100916 20100916172814 ACCESSION NUMBER: 0001181431-10-047024 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100914 FILED AS OF DATE: 20100916 DATE AS OF CHANGE: 20100916 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDIVATION, INC. CENTRAL INDEX KEY: 0001011835 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133863260 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 SPEAR STREET, 3RD FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 415-543-3470 MAIL ADDRESS: STREET 1: 201 SPEAR STREET, 3RD FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 FORMER COMPANY: FORMER CONFORMED NAME: ORION ACQUISITION CORP II DATE OF NAME CHANGE: 19960408 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: QVT Associates GP LLC CENTRAL INDEX KEY: 0001290166 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32836 FILM NUMBER: 101076685 BUSINESS ADDRESS: STREET 1: 1177 AVENUE OF THE AMERICAS STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 212-705-8800 MAIL ADDRESS: STREET 1: 1177 AVENUE OF THE AMERICAS STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 4 1 rrd286492.xml FORM 4 X0303 4 2010-09-14 0 0001011835 MEDIVATION, INC. MDVN 0001290166 QVT Associates GP LLC 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036 0 0 1 0 Common Stock, $0.01 par value 2010-09-14 4 P 0 13154 11.48 A 3704955 I Through QVT Fund LP and Quintessence Fund L.P. Common Stock, $0.01 par value 2010-09-14 4 P 0 18315 11.47 A 3723270 I Through QVT Fund LP and Quintessence Fund L.P. On September 14, 2010, QVT Fund LP purchased a total of 28,454 shares of Common Stock and Quintessence Fund L.P. purchased a total of 3,015 shares of Common Stock. As a result, QVT Fund LP directly beneficially owns 1,444,750 shares of Common Stock and Quintessence Fund L.P. directly beneficially owns 413,754 shares of Common Stock. QVT Associates GP LLC, as General Partner of QVT Fund LP and Quintessence Fund L.P., may be deemed to beneficially own the aggregate number of shares of Common Stock owned by QVT Fund LP and Quintessence Fund L.P., as well as the shares held by all of the other entities to which it serves as General Partner, and accordingly, QVT Associates GP LLC may be deemed to be the indirect beneficial owner of an aggregate amount of 3,723,270 shares of Common Stock. The reporting person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. /s/ Daniel Gold, Managing Member 2010-09-16 -----END PRIVACY-ENHANCED MESSAGE-----